In addition, starting at a lower dose tends to reduce or eliminate these symptoms
As patients lose weight on GLP-1 therapy, increased mobility often becomes feasible, creating opportunities for enhanced physical activity that further supports weight management and joint function
Here are some other key benefits: GLP-1 receptor agonists are generally well tolerated, but like all medications, they can cause side effects especially in the initial stages of treatment as the body adjusts to the hormonal changes or if a patient has not been counselled appropriately prior
In times requiring relief from pain so intense that it is affecting sleep, nutrition, and functionalitypain relief must be prioritized
Selected Primary Research Ipamorelin, the first selective growth-hormone secretagogue
Orforglipron is the first small molecule to act as an oral GLP-1 agonist"